These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35959787)
1. The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma. Karaman E; Hursoy N; Goksel S Nutr Cancer; 2023; 75(1):286-295. PubMed ID: 35959787 [TBL] [Abstract][Full Text] [Related]
2. The relationship between sarcopenia and metabolic parameters of Xu X; Zhou J; Yao X; Sang S; Li J; Wang B; Yang Y; Zhang B; Deng S Quant Imaging Med Surg; 2024 Oct; 14(10):7098-7110. PubMed ID: 39429564 [TBL] [Abstract][Full Text] [Related]
3. Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment Tan X; Sun X; Chen Y; Wang F; Shang Y; Zhang Q; Yuan H; Jiang L Korean J Radiol; 2024 Mar; 25(3):277-288. PubMed ID: 38413112 [TBL] [Abstract][Full Text] [Related]
4. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis. Katsui K; Ogata T; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S Sci Rep; 2021 Jun; 11(1):11882. PubMed ID: 34088965 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer. Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994 [TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408 [TBL] [Abstract][Full Text] [Related]
7. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293 [TBL] [Abstract][Full Text] [Related]
8. The predictive value of Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034 [TBL] [Abstract][Full Text] [Related]
9. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer. Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482 [TBL] [Abstract][Full Text] [Related]
10. Utility of multidetector computed tomography quantitative measurements in identifying sarcopenia: a propensity score matched study. Zuo YQ; Gao ZH; Wang Z; Liu Q; Yang X; Yin YL; Feng PY Skeletal Radiol; 2022 Jun; 51(6):1303-1312. PubMed ID: 34757481 [TBL] [Abstract][Full Text] [Related]
11. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival. Kiss N; Beraldo J; Everitt S Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer. Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967 [TBL] [Abstract][Full Text] [Related]
13. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415 [TBL] [Abstract][Full Text] [Related]
15. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Stene GB; Helbostad JL; Amundsen T; Sørhaug S; Hjelde H; Kaasa S; Grønberg BH Acta Oncol; 2015 Mar; 54(3):340-8. PubMed ID: 25225010 [TBL] [Abstract][Full Text] [Related]
16. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma. Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305 [TBL] [Abstract][Full Text] [Related]
17. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery. Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659 [TBL] [Abstract][Full Text] [Related]
18. Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy. Abe H; Takei K; Uematsu T; Tokura Y; Suzuki I; Sakamoto K; Nishihara D; Yamaguchi Y; Mizuno T; Nukui A; Kobayashi M; Kamai T Int J Clin Oncol; 2018 Apr; 23(2):338-346. PubMed ID: 29098519 [TBL] [Abstract][Full Text] [Related]
19. Low muscle mass determined by psoas muscle area does not correlate with dual-energy x-ray absorptiometry or total lumbar muscle mass scores: A prospective cohort study of patients undergoing vascular surgery. Thurston BE; Thomas JM; Miller M; Delaney CL Vascular; 2023 Feb; 31(1):107-114. PubMed ID: 35104187 [No Abstract] [Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]